Notch signaling in cardiac valve development and disease

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 6, 2011, Pages 449-459

  Macgrogan, Donal ^a   Luna Zurita, Luis ^a   de la Pompa, José Luis ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Cardiac valve development and disease; EMT; LVOTO; Notch signaling; RVOTO

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1;

AORTA VALVE DISEASE; ATRIOVENTRICULAR CANAL; BICUSPID AORTIC VALVE; CALCIFICATION; CONGENITAL HEART MALFORMATION; GENE DELETION; GENE MUTATION; GENE TARGETING; GENETIC MANIPULATION; GENOTYPE; HEART DEVELOPMENT; HEART DISEASE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE; HOMEOSTASIS; HUMAN; INFUNDIBULAR PULMONARY VALVE STENOSIS; MESENCHYME; MOLECULAR DYNAMICS; MORPHOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENE; VEIN BLOOD FLOW;

EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DEFECTS, CONGENITAL; HEART VALVES; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 79958150217     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20815     Document Type: Review

References (96)

1. Armstrong EJ, Bischoff J. 2004. Heart valve development: endothelial cell signaling and differentiation. Circ Res 95: 459-470.
2. Artavanis-Tsakonas S, Rand MD, Lake RJ, et al. 1999. Notch signaling: cell fate control and signal integration in development. Science 284770-776.
3. Aybar MJ, Nieto MA, Mayor R, et al. 2003. Snail precedes slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development 130: 483-494.
4. Bailliard F, Anderson RH. 2009. Tetralogy of Fallot. Orphanet J Rare Dis 4: 2.
5. Bauer RC, Laney AO, Smith R, et al. 2010. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat 31594-601.
6. Bolos V, Grego-Bessa J, de la Pompa JL. 2007. Notch signaling in development and cancer. Endocr Rev 28339-363.
7. Boyer AS, Ayerinskas II, Vincent EB, et al. 1999. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 208: 530-545.
8. Braverman AC, Guven H, Beardslee MA, et al. 2005. The bicuspid aortic valve. Curr Probl Cardiol 30: 470-522.
9. Bruneau BG. 2008. The developmental genetics of congenital heart disease. Nature 451: 943-948.
10. Butcher JT, Markwald RR. 2007. Valvulogenesis: the moving target. Philos Trans R Soc Lond B Biol Sci 362: 1489-1503.
11. Butcher JT, Simmons CA, Warnock JN, et al. 2008. Mechanobiology of the aortic heart valve. J Heart Valve Dis 17: 62-73.
12. Cai CL, Zhou W, Yang L, et al. 2005. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 132: 2475-2487.
13. Camenisch TD, Molin DG, Person A, et al. 2002. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248: 170-181.
14. Chabriat H, Joutel A, Dichgans M, et al. Cadasil Lancet Neurol 2009; 8: 643-653.
15. Christianson A, Modell B. 2004. Medical genetics in developing countries. Annu Rev Genomics Hum Genet 5: 219-265.
16. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. 2004. Bicuspid aortic valve is heritable. J Am Coll Cardiol 44: 138-143.
17. Crosnier C, Driancourt C, Raynaud N, et al. 1999. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. Gastroenterology 116 1141-1148.
18. Del Monte G, Grego-Bessa J, Gonzalez-Rajal A, et al. 2007. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn 2362594-2614.
19. Demarest RM, Ratti F, Capobianco AJ, et al. 2008. It's T-ALL about Notch. Oncogene 27: 5082-5091.
20. Donovan J, Kordylewska A, Jan YN, et al. 2002. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12: 1605-1610.
21. Eisenberg LM, Markwald RR. 1995. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77: 1-6.
22. Eldadah ZA, Hamosh A, Biery NJ, et al. 2001. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet 10163-169.
23. Fischer A, Steidl C, Wagner TU, et al. 2007. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 100: 856-863.
24. Fortini ME, Artavanis-Tsakonas S. 1994. The suppressor of hairless protein participates in notch receptor signaling. Cell 79: 273-282.
25. Freeman RV, Otto CM. 2005. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111: 3316-3326.
26. Friedman T, Mani A, Elefteriades JA, et al. 2008. Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity. Expert Rev Cardiovasc Ther 6: 235-248.
27. Garg V. 2006. Molecular genetics of aortic valve disease. Curr Opin Cardiol 21: 180-184.
28. Garg V, Muth AN, Ransom JF, et al. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270-274.
29. Gessler M, Knobeloch KP, Helisch A, et al. 2002. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol 12: 1601-1604.
30. Goldbarg SH, Elmariah S, Miller MA, et al. 2007. Insights into degenerative aortic valve disease. J Am Coll Cardiol 50: 1205-1213.
31. Goldmuntz E, Moore E, Spinner NB, et al. 2006. The cardiovascular manifestations of Alagille syndrome and JAGI mutations. Methods Mol Med 126: 217-231.
32. Grau JB, Pirelli L, Yu PJ, et al. 2007. The genetics of mitral valve prolapse. Clin Genet 72: 288-295.
33. Greenway SC, Pereira AC, Lin JC, et al. 2009. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 41: 931-935.
34. Harrelson Z, Kelly RG, Goldin SN, et al. 2004. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131: 5041-5052.
35. High FA, Jain R, Stoller JZ, Antonucci NB, Lu MM, Loomes KM, Kaestner KH, Pear WS, Epstein JA. 2009. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J Clin Invest 119: 1986-1996.
36. High FA, Zhang M, Proweller A, et al. 2007. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 117: 353-363.
37. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890-1900
38. Iso T, Kedes L, Hamamori Y, et al. 2003. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255.
39. Kaartinen V, Voncken JW, Shuler C, et al. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11: 415-421.
40. Kokubo H, Miyagawa-Tomita S, Nakazawa M, et al. 2005. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol 278: 301-309.
41. Kokubo H, Miyagawa-Tomita S, Tomimatsu H, et al. 2004. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ Res 95: 540-547.
42. Kokubo H, Tomita-Miyagawa S, Hamada Y, et al. 2007. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 134: 747-755.
43. Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233.
44. Krantz ID, Colliton RP, Genin A, et al. 1998. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 62: 1361-1369.
45. Krantz ID, Smith R, Colliton RP, et al. 1999. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet 84: 56-60.
46. Le Caignec C, Lefevre M, Schott JJ, et al. 2002. Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1. Am J Hum Genet 71: 180-186.
47. Li L, Krantz ID, Deng Y, et al. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16: 243-251.
48. Lincoln J, Lange AW, Yutzey KE, et al. 2006. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol 294: 292-302.
49. Loffredo CA. 2000. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet 97: 319-325.
50. Logeat F, Bessia C, Brou C, et al. 1998. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A 95: 8108-8112.
51. Loomes KM, Taichman DB, Glover CL, et al. 2002. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 112: 181-189.
52. Loomes KM, Underkoffler LA, Morabito J, et al. 1999. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum Mol Genet 8: 2443-2449.
53. Lu F, Morrissette JJ, Spinner NB, et al. 2003. Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage. Am J Hum Genet 72: 1065-1070.
54. Luna-Zurita L, Prados B, Grego-Bessa J, et al. 2010. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J Clin Invest 120: 3493-3507.
55. Ma L, Lu MF, Schwartz RJ, et al. 2005. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611.
56. Martin LJ, Ramachandran V, Cripe LH, Hinton RB, Andelfinger G, Tabangin M, Shooner K, Keddache M, Benson DW. 2007. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet 121: 275-284.
57. McBride KL, Riley MF, Zender GA, et al. 2008. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 17: 2886-2893.
58. McCright B, Lozier J, Gridley T, et al. 2002. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129: 1075-1082.
59. McDaniell R, Warthen DM, Sanchez-Lara PA, et al. 2006. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 79: 169-173.
60. McElhinney DB, Krantz ID, Bason L, et al. 2002. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106: 2567-2574.
61. MacGrogan D, Nus M, de la Pompa JL. 2010. Notch signaling in cardiac development and disease. Curr Top Dev Biol 92: 333-365.
62. McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TM, 3rd. 2007. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 134: 290-296.
63. Morrissette JD, Colliton RP, Spinner NB, et al. 2001. Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome. Hum Mol Genet 10: 405-413.
64. Nakagawa O, Nakagawa M, Richardson JA, Olson EN, Srivastava D. 1999. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol 216: 72-84.
65. Niessen K, Fu Y, Chang L, et al. 2008. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 182: 315-325.
66. Nigam V, Srivastava D. 2009. Notch1 represses osteogenic pathways in aortic valve cells. J Mol Cell Cardiol 47: 828-834.
67. O'Brien KD. 2006. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26: 1721-1728.
68. Oda T, Elkahloun AG, Pike BL, et al. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16: 235-242 lineage decision.
69. Otto CM. 2009. Calcific aortic valve disease: outflow obstruction is the end stage of a systemic disease process. Eur Heart J 30: 1940-1942.
70. Person AD, Klewer SE, Runyan RB, et al. 2005. Cell biology of cardiac cushion development. Int Rev Cytol 243: 287-335.
71. Restivo A, Piacentini G, Placidi S, et al. 2006. Cardiac outflow tract: a review of some embryogenetic aspects of the conotruncal region of the heart. Anat Rec A Discov Mol Cell Evol Biol 288: 936-943.
72. Riley MF, McBride KL, Cole SE. 2010. NOTCH1 missense alleles associated with left ventricular outflow tract defects exhibit impaired receptor processing and defective EMT. Biochim Biophys Acta 1812: 121-129.
73. Rivera-Feliciano J, Tabin CJ. 2006. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev Biol 295: 580-588.
74. Rochais F, Dandonneau M, Mesbah K, et al. 2009. Hes1 is expressed in the second heart field and is required for outflow tract development. PLoS One 4: e6267.
75. Rutenberg JB, Fischer A, Jia H, et al. 2006. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 133: 4381-4390.
76. Schroeder JA, Jackson LF, Lee DC, et al. 2003. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 81: 392-403.
77. Shah PM, Raney AA. 2008. Tricuspid valve disease. Curr Probl Cardiol 33: 47-84.
78. Shirai M, Imanaka-Yoshida K, Schneider MD, et al. 2009. T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc Natl Acad Sci U S A 106: 18604-18609.
79. Singh MK, Christoffels VM, Dias JM, et al. 2005. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development 132: 2697-2707.
80. Singh R, Horsthuis T, Farin HF, et al. 2009. Tbx20 interacts with Smads to confine tbx2 expression to the atrioventricular canal. Circ Res 105: 442-452.
81. Siu SC, Silversides CK. 2010. Bicuspid aortic valve disease. J Am Coll Cardiol 55: 2789-2800.
82. Spinner NB. 1999. Alagille syndrome and the notch signaling pathway: new insights into human development. Gastroenterology 116: 1257-1260.
83. Spinner NB, Colliton RP, Crosnier C, et al. 2001. Jagged1 mutations in alagille syndrome. Hum Mutat 17: 18-33.
84. Stennard FA, Costa MW, Lai D, et al. 2005. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 132: 2451-2462.
85. Supino PG, Borer JS, Preibisz J, et al. 2006. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin 2: 379-393.
86. Surendran K, Boyle S, Barak H, et al. 2010. The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mint dosage. Dev Biol 337: 386-395.
87. Timmerman LA, Grego-Bessa J, Raya A, et al. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18: 99-115.
88. Towbin JA, Belmont J. 2000. Molecular determinants of left and right outflow tract obstruction. Am J Med Genet 97: 297-303.
89. Vincent SD, Buckingham ME. 2010. How to make a heart: the origin and regulation of cardiac progenitor cells. Curr Top Dev Biol 90: 1-41.
90. Vooijs M, Ong CT, Hadland B, et al. 2007. Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development 134: 535-544.
91. Warthen DM, Moore EC, Kamath BM, et al. 2006. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat 27: 436-443.
92. Watanabe Y, Kokubo H, Miyagawa-Tomita S, et al. 2006. Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse. Development 133: 1625-1634.
93. Xu S, Liu AC, Gotlieb AI. 2009. Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta. Cardiovasc Pathol 19: 236-237.
94. Xue Y, Gao X, Lindsell CE, et al. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8: 723-730.
95. Yamada M, Revelli JP, Eichele G, et al. 2000. Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2 Dev Biol 228: 95-105.
96. Yang X, Meng X, Su X, et al. 2009. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. J Thorac Cardiovasc Surg 138: 1008-1015.